Updated Lipid Guidelines Emphasize Early Intervention and Lp(a) Assessment

Published: March 15, 2026

New guidelines for managing dyslipidemia, released jointly by the American Heart Association and the American College of Cardiology, prioritize early lifestyle interventions and consideration of medical therapy, even in young adults. A significant focus of the updated recommendations is the assessment and management of lipoprotein(a) [Lp(a)], a cholesterol-like substance increasingly recognized as a key risk factor for cardiovascular disease.

Key Recommendations and Updates

The updated guideline, developed in collaboration with several cardiovascular and preventative medicine organizations, including the American Association of Cardiovascular and Pulmonary Rehabilitation and the National Lipid Association, represents a significant evolution in the approach to dyslipidemia management. It was published in Circulation and the Journal of the American College of Cardiology.

Early Intervention and Risk Prediction

The guidelines emphasize the importance of initiating comprehensive lifestyle modifications earlier in life and continuing them throughout adulthood to reduce the risk of heart attack and stroke. New tools for assessing cardiovascular risk, such as the AHA’s PREVENT equations, are recommended over older methods like the Pooled Cohort Equations. The PREVENT equation, derived from real-world data including over 6 million adults, incorporates factors like kidney function, social determinants of health, and blood glucose levels, providing a more personalized risk assessment. Healio

Lipoprotein(a) Assessment

The updated guidelines place a greater emphasis on Lp(a) than previous iterations. Measurement of Lp(a) is now recommended at least once in a patient’s lifetime. Elevated Lp(a) levels (exceeding 125 nmol/L or 50 mg/dL) are considered a significant risk factor and should prompt intensified LDL and overall risk management. While there are currently no FDA-approved treatments specifically for lowering Lp(a), several are under development. Healio

Coronary Artery Calcium (CAC) Scoring

The guidelines recommend CAC scoring for men aged 40 years or older and women aged 45 years or older to refine ASCVD risk assessment and guide management of atherogenic lipids.

LDL-Lowering Guidance

Specific LDL-lowering guidance is provided for various patient populations, including those with a 10-year estimated ASCVD risk of 3% to 5%, adults aged 40 to 75 years with diabetes, stage 3 or 4 chronic kidney disease, or HIV, and those in secondary prevention with a very high risk of ASCVD events.

Expert Perspectives

“Dyslipidemia, or high cholesterol, refers to abnormal levels of lipids. They can be a low HDL cholesterol, a high LDL cholesterol and elevated triglycerides or a combination. Now we have a much greater emphasis in our guidelines about lipoprotein(a), a cholesterol-like substance. Elevated Lp(a) is also one type of dyslipidemia,” said Roger S. Blumenthal, MD, FACC, FAHA, director of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease. “We know that each of these lipid abnormalities can contribute to the buildup of fatty deposits in the arteries, and that leads to both a higher risk of heart attack and stroke.” Healio

Pamela B. Morris, MD, FACC, FAHA, Paul V. Palmer chair of cardiovascular disease prevention, emphasized the importance of early action, stating, “Taking action early in life is critical because high cholesterol begins to impact your heart disease risk even in adolescence.” Healio

Looking Ahead

The implementation of these updated guidelines is expected to significantly impact the prevention and management of cardiovascular disease. Continued research and development of therapies targeting Lp(a) will be crucial in further reducing the burden of this prevalent condition.